Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 5, 2004, Pages 848-852

  Pfausler, Bettina ^a   Spiss, Heinrich ^a   Dittrich, Peter ^b   Zeitlinger, Markus ^c   Schmutzhard, Erich ^a   Joukhadar, Christian ^c  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

CSF; Humans; Intensive care; Pharmacokinetics

Indexed keywords

AMIKACIN; CEFTAZIDIME; CLINDAMYCIN; DOBUTAMINE; DOPAMINE; FOSFOMYCIN; METICILLIN; NETILMICIN; NORADRENALIN; PENICILLIN G; PHENYLEPHRINE;

ADULT; ANASTOMOSIS; ANTIBIOTIC SENSITIVITY; AREA UNDER THE CURVE; ARTICLE; BRAIN VENTRICULITIS; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID DRAINAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PENETRATION; FEMALE; GROWTH INHIBITION; HUMAN; HYDROCEPHALUS; IN VITRO STUDY; INTENSIVE CARE; MALE; MICROBIAL GROWTH; MINIMUM INHIBITORY CONCENTRATION; PATHOGENESIS; PATIENT MONITORING; SIDE EFFECT; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STEADY STATE;

ADULT; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BIOLOGICAL ASSAY; CEREBRAL VENTRICLES; FEMALE; FOSFOMYCIN; HALF-LIFE; HUMANS; INTENSIVE CARE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEUROSURGICAL PROCEDURES; VENTRICULOSTOMY;

EID: 2442719001     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh158     Document Type: Article

References (26)

1. Pfausler, B., Spiss, H., Beer, R. et al. (2003). Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. Journal of Neurosurgery 98, 1040-4.
2. Zeitlinger, M. A., Marsik, C., Georgopoulos, A. et al. (2003). Target site bacterial killing of cefpirome and fosfomycin in critically ill patients. International Journal of Antimicrobial Agents 21, 562-7.
3. Ungheri, D., Albini, E. & Belluco, G. (2002). In-vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol. Journal of Chemotherapy 14, 237-40.
4. Garcia-Rodriguez, J. A., Trujillano, M. I., Baquero, F. et al. (1997). In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study. Journal of Chemotherapy 9, 394-402.
5. Frossard, M., Joukhadar, C., Erovic, B. M. et al. (2000). Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues. Antimicrobial Agents and Chemotherapy 44, 2728-32.
6. Joukhadar, C., Klein, N., Dittrich, P. et al. (2003). Target site penetration of fosfomycin in critically ill patients. Journal of Antimicrobial Chemotherapy 51, 1247-52.
7. Legat, F. J., Maier, A., Dittrich, P. et al. (2003). Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome. Antimicrobial Agents and Chemotherapy 47, 371-4.
8. Grif, K., Dierich, M. P., Pfaller, K. et al. (2001). In vitro activity of fosfomycin in combination with various antistaphylococcal substances. Journal of Antimicrobial Chemotherapy 48, 209-17.
9. Dios-Vieitez, M. C., Goni, M. M., Renedo, M. J. et al. (1996). Determination of fosfomycin in human urine by capillary gas chromatography: application to clinical pharmacokinetic studies. Chromatographia 43, 293-5.
10. National Committee for Clinical Laboratory Standards, (2002). Performance Standards for Antimicrobial Susceptibility Testing - Twelfth Informational Supplement M100-S12. NCCLS, Wayne, PA, USA.
11. Gould, I. M. & MacKenzie, F. M. (2002). Antibiotic exposure as a risk factor for emergence of resistance: the influence of concentration. Journal of Applied Microbiology 92, Suppl., 78S-84S.
12. Huovinen, P. (2002). Macrolide-resistant group A Streptococcus - now in the United States. New England Journal of Medicine 346, 1243-5.
13. Dagan, R., Klugman, K. P., Craig, W. A. et al. (2001). Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. Journal of Antimicrobial Chemotherapy 47, 129-40.
14. Brunner, M., Reinprecht, A., Illievich, U. et al. (2002). Penetration of fosfomycin into the parenchyma of human brain: a case study in three patients. British Journal of Clinical Pharmacology 54, 548-50.
15. Kuhnen, E., Pfeifer, G. & Frenkel, C. (1987). Penetration of fosfomycin into cerebrospinal fluid across non-inflamed and inflamed meninges. Infection 15, 422-4.
16. Hyatt, J. M., McKinnon, P. S., Zimmer, G. S. et al. (1995). The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents. Clinical Pharmacokinetics, 28, 143-60.
17. Scaglione, F. (2002). Can PK/PD be used in everyday clinical practice? International Journal of Antimicrobial Agents 19, 349-53.
18. Craig, W. A. (1995). Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagnostic Microbiology and Infectious Disease 22, 89-96.
19. Vogelman, B., Gudmundsson, S., Leggett, J. et al. (1988). Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. Journal of Infectious Diseases 158, 831-47.
20. Leggett, J. E., Fantin, B., Ebert, S. et al. (1989). Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. Journal of Infectious Diseases 159, 281-92.
21. Roosendaal, R., Bakker-Woudenberg, I. A., van den Berg, J. C. et al. (1985). Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats. Journal of Infectious Diseases 152, 373-8.
22. Van der Auwera, P., Godard, C., Denis, C. et al. (1990). In vitro activities of new antimicrobial agents against multiresistant Staphylococcus aureus isolated from septicemic patients during a Belgian national survey from 1983 to 1985. Antimicrobial Agents and Chemotherapy 34, 2260-2.
23. Takahashi, A., Yomoda, S., Tanimoto, K. et al. (1998). Streptococcus pyogenes hospital-acquired infection within a dermatological ward. Journal of Hospital Infection 40, 135-40.
24. Pardo, Z. A., Gimeno, B. L. & Andonegui, O. J. (1977), Evaluation of fosfomycin in an intensive care unit. Chemotherapy23, Suppl. 1, 411-5.
25. Borowski, J. & Linda, H. (1977). Combined action of fosfomycin with β-lactam and aminoglycoside antibiotics. Chemotherapy 23, Suppl. 1, 82-5.
26. Pea, F., Pavan, F., Nascimben, E., et al. (2003). Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy. Antimicrobial Agents and Chemotherapy 47, 3104-8.